1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AMGEN INC.
AMGEN Inc. XNAS: AMGN

Amgen Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

Read More
375.38 -1.59 (-0.42%)
Near 52W High of $391.29
328.2K
XNAS Volume

XNAS 10 Mar, 2026 10:48 AM (EDT)

Watchlist

Portfolio

Alert
Dividend
Amgen has an upcoming dividend of $2.52 per share due on 15 May 2026 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
42.0 / 100
Momentum Score
Technically Moderately Bullish
61.6 / 100
Momentum Trap These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks View Similar Embed DVM
Analyst Price Target
350
1Yr Price target downside is -7%
28 analysts

9

S

9

W

5

O

0

T

SWOT Analysis

Amgen Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..